Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials.
about
Clinical management of infections caused by multidrug-resistant EnterobacteriaceaeAn update on the management of urinary tract infections in the era of antimicrobial resistance.The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study.Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series.Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance.The erratic antibiotic susceptibility patterns of bacterial pathogens causing urinary tract infections.Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database.Low Concordance With Guidelines for Treatment of Acute Cystitis in Primary Care.Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance.FosfomycinFosfomycin: Resurgence of an old companion.Recurrent Urinary Tract Infections Management in Women: A reviewCharacterization of Two Late-Stage Enzymes Involved in Fosfomycin Biosynthesis in Pseudomonads.Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario.Revisiting "older" antimicrobials in the era of multidrug resistance.Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens.Current and prospective treatments for multidrug-resistant gram-positive infections.Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.The challenge of antibiotic resistance in haematology patients.Role of old antimicrobial agents in the management of urinary tract infection.Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.Fosfomycin: Mechanism and Resistance.Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: a prospective study.Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.Editorial Commentary: Fosfomycin: The Current Status of the Drug.An update on new antibiotic prophylaxis and treatment for urinary tract infections in children.Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens.Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark.Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.Fosfomycin Susceptibility in Multidrug-Resistant Enterobacteriaceae Species and Vancomycin-Resistant Enterococci Urinary Isolates.Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.Uncomplicated Bacterial Communityacquired Urinary Tract Infection in Adults.Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections.
P2860
Q28246841-8C394CA3-F205-4A24-975D-78AD0F18602DQ30244815-CDE415BF-D27B-45DE-A0EF-DD430033C815Q34654002-3E210489-C759-464D-9E37-B9AA42F49ED6Q35115778-A6ED24F6-29F9-4B1C-A6EC-D348A2C4FEBBQ36290521-82F056B0-59E4-4E02-9F35-DEEC6064699DQ36347562-2D11B697-4DE6-4553-B192-EE5AAA3939DDQ36363257-E61D7368-6910-4DC9-BDA2-82019C5C5502Q36363646-F52526E1-1E09-48FF-8CA8-79D2A7B3592FQ36476574-A3CA0CE3-174C-4556-94AC-53259412B3A6Q36675246-00E7F9CC-FDC6-4288-B513-D6C663D9C4B0Q36803694-AB55787C-67A6-425B-8833-B2986A2AE5CEQ37109572-697AD98F-F252-434A-8B56-D9885EA59E01Q37650512-4D2CB7D9-76FF-4182-B8DD-AFD9A32E9D2FQ37681591-03695E52-32DF-470F-80D7-F5DD90D307E9Q37933412-10CC353E-1576-4D9D-A860-E12F8CB5F8B0Q37957839-20A5E502-7413-46CE-A115-BF44EC9484FEQ38078878-E8335F62-5A27-4C9A-BEAA-2658F9D7D387Q38123255-6AA3B309-D8C3-46A4-A511-F25ED79FB930Q38160759-6D99444D-1EB5-43A0-850B-4F4F0227F411Q38613929-F438D1C0-5CFE-4D9F-8776-7057EBB0782EQ38832723-0B45C00F-B337-4907-9256-92C618A7E616Q38849466-A14FDAE5-DC37-4060-B0AF-3AF5D42EAA11Q39071416-8D123540-DC4E-4E9B-83AC-80EFF73ABAE5Q39425303-84126984-B9FF-439E-B6E6-D807356F7DD0Q40166194-455302C6-596F-4413-A034-E58A195BAE23Q40587151-E57D4DA0-8110-4FBA-AB17-1CD319F39EBEQ40886408-70E375B7-5AD9-492A-A107-9427F3ABF4F4Q41169961-838C3DB1-F403-4CB4-A4C6-DF31826E6F2FQ41993659-F8C229AE-68AC-40CF-9178-9898ED908FACQ42102558-B3950E93-869F-4106-B40D-6F589CA5826DQ42261308-59D6ED62-31A1-4C32-85EB-126CA89F836BQ42374450-59907F0A-C5F0-440E-89E3-DD3AD9C85CCEQ43807763-3B3C47F8-38EF-4D63-B5CD-CB171ED428B2Q44492534-86F8A8C6-F970-4C38-8CD9-17F4274A1B22Q46267399-28ED4DB2-8422-4D5F-A900-EC0AA1437B6EQ48165659-3F867F12-0D6E-40D0-85D0-DDF6ED89282FQ49207482-279E4639-F77B-4CED-8171-D6E7A36F4594Q53074500-33B3968A-2EE4-4597-BC13-C3DFE13D6C1E
P2860
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fosfomycin versus other antibi ...... randomized controlled trials.
@en
Fosfomycin versus other antibi ...... randomized controlled trials.
@nl
type
label
Fosfomycin versus other antibi ...... randomized controlled trials.
@en
Fosfomycin versus other antibi ...... randomized controlled trials.
@nl
prefLabel
Fosfomycin versus other antibi ...... randomized controlled trials.
@en
Fosfomycin versus other antibi ...... randomized controlled trials.
@nl
P2093
P356
P1476
Fosfomycin versus other antibi ...... randomized controlled trials.
@en
P2093
Anastasios M Kapaskelis
Antonios G Togias
Evridiki K Vouloumanou
Maria Karadima
Stavros Athanasiou
P304
P356
10.1093/JAC/DKQ237
P407
P577
2010-06-29T00:00:00Z